The neurobiology of repetitive behavior: ...and men

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 3, 2011, Pages 356-365

  Langen, Marieke ^a   Durston, Sarah ^a   Kas, Martien J H ^a   van Engeland, Herman ^a   Staal, Wouter G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autism; Basal ganglia; Corticostriatal circuitry; Huntington; Neurodevelopmental disorders; OCD; Parkinson; Repetitive behavior; Stereotypy; Striatum; Tourette

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE;

ATTENTION DEFICIT DISORDER; AUTISM; BASAL GANGLION; BRAIN CORTEX; CLINICAL FEATURE; COGNITION; COMPULSION; CORPUS STRIATUM; DAILY LIFE ACTIVITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DOPAMINERGIC TRANSMISSION; EVOKED RESPONSE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; LOW DRUG DOSE; NERVOUS SYSTEM DEVELOPMENT; NEUROANATOMY; NEUROBIOLOGY; NEUROIMAGING; NEUROMODULATION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOPATHY; REVIEW; SENSORIMOTOR FUNCTION; SEROTONINERGIC TRANSMISSION; SYMPTOM; TIC;

ANIMALS; AUTISTIC DISORDER; CEREBRAL CORTEX; CORPUS STRIATUM; HUMANS; HUNTINGTON DISEASE; NEURAL PATHWAYS; NEUROBIOLOGY; OBSESSIVE-COMPULSIVE DISORDER; PARKINSON DISEASE; STEREOTYPED BEHAVIOR; TOURETTE SYNDROME;

EID: 78649905436     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.02.005     Document Type: Review

References (162)

1. Abramson R.K., Ravan S.A., Wright H.H., Wieduwilt K., Wolpert C.M., Donnelly S.A., et al. The relationship between restrictive and repetitive behaviors in individuals with autism and obsessive compulsive symptoms in parents. Child Psychiatry and Human Development 2005, 36(2):155-165.
2. Albin R.L., Koeppe R.A., Bohnen N.I., Nichols T.E., Meyer P., Wernette K., et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003, 61(3):310-315.
3. Albin R.L., Mink J.W. Recent advances in Tourette syndrome research. Trends in Neurosciences 2006, 29(3):175-182.
4. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neurosciences 1989, 12(10):366-375.
5. Amaral D.G., Schumann C.M., Nordahl C.W. Neuroanatomy of autism. Trends in Neurosciences 2008, 31(3):137-145.
6. American Psychiatric Association, 2000. Diagnostic and statistical manual of mental disorders (Fourth edition, text revision).
7. Anderson, Pollak E.S., Chatterjee D., Leckman, Riddle M.A., Cohen D.J. Brain monoamines and amino acids in Gilles de la Tourette's syndrome: a preliminary study of subcortical regions. Archives of General Psychiatry 1992, 49(7):584-586.
8. Aouizerate B. Pathophysiology of obsessive-compulsive disorder a necessary link between phenomenology, neuropsychology, imagery and physiology. Progress in Neurobiology 2004, 72(3):195-221.
9. Asperger H. Die 'autistischen psychopathen' im kindesalter. Archiv fur Psychiatrie und Nervenkrankheiten 1944, 117:76-136.
10. Aylward E.H., Harris G.J., Hoehn-Saric R., Barta P.E., Machlin S.R., Pearlson G.D. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Archives of General Psychiatry 1996, 53(7):577-584.
11. Barnard, Young, Pearson, Geddes, O'Brien A systematic review of the use of atypical antipsychotics in autism. Journal of Psychopharmacology (Oxford) 2002, 16(1):93-101.
12. Bartha R., Stein M.B., Williamson P.C., Drost D.J., Neufeld R.W., Carr T.J., et al. A short echo 1h spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. The American Journal of Psychiatry 1998, 155(11):1584-1591.
13. Baxter L.R. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. The Journal of Clinical Psychiatry 1990, 51(Suppl.):22-25. discussion 26.
14. Baxter L.R., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Archives of General Psychiatry 1987, 44(3):211-218.
15. Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry 1992, 49(9):681-689.
16. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy, Cohen R.M. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Archives of General Psychiatry 1990, 47(9):840-848.
17. Berardelli A., Currà A., Fabbrini G., Gilio F., Manfredi M. Pathophysiology of tics and Tourette syndrome. Journal of Neurology 2003, 250(7):781-787.
18. Biswal B., Ulmer J.L., Krippendorf R.L., Harsch H.H., Daniels D.L., Hyde J.S., et al. Abnormal cerebral activation associated with a motor task in Tourette syndrome. AJNR American Journal of Neuroradiology 1998, 19(8):1509-1512.
19. Bloch, Landeros-Weisenberger A., Kelmendi B., Coric V., Bracken, Leckman A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry 2006, 11(7):622-632.
20. Bloch M.H., Leckman J.F., Zhu H.T., Peterson B.S. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65:1253-1258.
21. Bodfish J.W., Symons F.J., Parker D.E., Lewis M.H. Varieties of repetitive behavior in autism: comparisons to mental retardation. Journal of Autism and Developmental Disorders 2000, 30(3):237-243.
22. Boyer P., Liénard P. Why ritualized behavior? Precaution systems and action parsing in developmental, pathological and cultural rituals. The Behavioral and Brain Sciences 2006, 29(6):595-613. discussion 613-50.
23. Braun A.R., Randolph C., Stoetter B., Mohr E., Cox C., Vladar K., et al. The functional neuroanatomy of Tourette's syndrome: an fdg-pet study. Ii: relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology 1995, 13(2):151-168.
24. Braun A.R., Stoetter B., Randolph C., Hsiao J.K., Vladar K., Gernert J., et al. The functional neuroanatomy of Tourette's syndrome: an fdg-pet study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 1993, 9(4):277-291.
25. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Archives of General Psychiatry 1996, 53(7):595-606.
26. Calabresi P., De Murtas M., Bernardi G. The neostriatum beyond the motor function: experimental and clinical evidence. Neuroscience 1997, 78(1):39-60.
27. Chamberlain S.R., Menzies L., Hampshire A., Suckling J., Fineberg N.A., del Campo N., et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008, 321(5887):421-422.
28. Chase T.N., Geoffrey V., Gillespie M., Burrows G.H. Structural and functional studies of Gilles de la Tourette syndrome. Revista de Neurologia (Paris) 1986, 142(11):851-855.
29. 123I]IPT SPECT in drug-naive children with Tourette's disorder. Psychiatry Research 2004, 130(1):85-95.
30. Cheyette S.R., Cummings J.L. Encephalitis lethargica: lessons for contemporary neuropsychiatry. The Journal of Neuropsychiatry and Clinical Neurosciences 1995, 7(2):125-134.
31. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 2001, 124(Pt 12):2503-2512.
32. De Jonge M.V., Kemner C., Naber F., Van Engeland H. Block design reconstruction skills: not a good candidate for an endophenotypic marker in autism research. European Child & Adolescent Psychiatry 2009, 18(4):197-205.
33. Delgado P.L., Moreno F. Different roles for serotonin in antiobsessional drug action and the pathophysiology of obsessive-compulsive disorder. Bristish Journal of Psychiatry Supplement 1998, 35:21-25.
34. Denys D., Zohar J., Westenberg H.G. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. The Journal of Clinical Psychiatry 2004, 65(Suppl. 14):11-17.
35. Dougherty D.D., Baer L., Cosgrove G.R., Cassem E.H., Price B.H., Nierenberg A.A., et al. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. The American Journal of Psychiatry 2002, 159(2):269-275.
36. Dove A., Pollmann S., Schubert T., Wiggins C.J., von Cramon D.Y. Prefrontal cortex activation in task switching: an event-related fMRI study. Brain Research Cognitive Brain Research 2000, 9(1):103-109.
37. Durston S., Casey B.J. A shift from diffuse to focal cortical activity with development: the authors' reply. Developmental Science 2006, 9(1):18-20.
38. Duvall J.A., Lu A., Cantor R.M., Todd R.D., Constantino J.N., Geschwind D.H. A quantitative trait locus analysis of social responsiveness in multiplex autism families. The American Journal of Psychiatry 2007, 164(4):656-662.
39. Eidelberg D., Moeller J.R., Antonini A., Kazumata K., Dhawan V., Budman C., et al. The metabolic anatomy of Tourette's syndrome. Neurology 1997, 48(4):927-934.
40. Ernst M., Zametkin A.J., Jons P.H., Matochik J.A., Pascualvaca D., Cohen R.M. High presynaptic dopaminergic activity in children with Tourette's disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1999, 38(1):86-94.
41. Evans A., Katzenschlager R., Paviour D., O'sullivan J., Appel S., Lawrence A., et al. Punding in parkinson's disease: its relation to the dopamine dysregulation syndrome. Movement Disorders 2004, 19(4):397-405.
42. Evans A., Lees A. Dopamine dysregulation syndrome in parkinson's disease. Current Opinion in Neurology 2004, 17(4):393-398.
43. Evans D. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder. Brain and Cognition 2004, 55(1):220-234.
44. Evans D.W., Leckman J.F., Carter A., Reznick J.S., Henshaw D., King R.A., Pauls D.L. Ritual, habit, and perfectionism: the prevalence and development of compulsive-like behavior in normal young children. Child Development 1997, 68(1):58-68.
45. Ferrier J. Medical Histories and Reflections 1795, Cadell and Davies, London.
46. Fineberg N.A., Saxena S., Zohar J., Craig K.J. Obsessive-compulsive disorder: boundary issues. CNS Spectr 2007, 12(5). 359-364, 367-375.
47. Fineberg N.A., Potenza M.N., Chamberlain S.R., Berlin H.A., Menzies L., Bechara A., et al. Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review. Neuropsychopharmacology 2009, 35:591-604.
48. Fitzgerald K.D., Welsh R.C., Gehring W.J., Abelson J.L., Himle J.A., Liberzon I., et al. Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biological Psychiatry 2005, 57(3):287-294.
49. Francois C., Grabli D., McCairn K., Jan C., Karachi C., Hirsch E.C., et al. Behavioural disorders induced by external globus pallidus dysfunction in primates: ii. Anatomical study. Brain 2004, 127(Pt 9):2055-2070.
50. Fredericksen K.A., Cutting L.E., Kates W.R., Mostofsky S.H., Singer H.S., Cooper K.L., et al. Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 2002, 58(1):85-89.
51. Frith C.D., Done D.J. Stereotypy in psychiatry. Neurobiology of Stereotyped Behaviour 1990, 232-259. Clarendon Press, Oxford. S.J. Cooper, C.T. Dourish (Eds.).
52. Gaffney G.R., Kuperman S., Tsai L.Y., Minchin S. Forebrain structure in infantile autism. Journal of the American Academy of Child and Adolescent Psychiatry 1989, 28(4):534-537.
53. Garner J.P. Perseveration and stereotypy: systems-level insights from clinical psychology. Stereotypic Animal Behaviour. Fundamentals and Applications to Welfare 2006, 121-152. CAB International, Wallingford. G. Mason, J. Rushen (Eds.).
54. George M.S., Trimble M.R., Costa D.C., Robertson M.M., Ring H.A., Ell P.J. Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: a 99tcm-hmpao spect study. Psychiatry Research 1992, 45(3):143-151.
55. Gesell A. Infancy and Human Growth 1928, Macmillan, New York.
56. Gesell A., Ames L.B., Ilg F.L. Infant and the Child in the Culture Today 1974, Harper & Row, New York.
57. Goddard A.W., Shekhar A., Whiteman A.F., McDougle C.J. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discovery Today 2008, 13(7-8):325-332.
58. Graybiel A.M., Rauch S.L. Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000, 28(2):343-347.
59. Grew N. Cosmologica Sacra: or a Discourse of the Universe as it is the Creature and Kingdom of God 1701, Rogers et al., London.
60. Haber S.N., Calzavara R. The cortico-basal ganglia integrative network: the role of the thalamus. Brain Research Bulletin 2009, 78(2-3):69-74.
61. Haznedar M.M., Buchsbaum M.S., Hazlett E.A., LiCalzi E.M., Cartwright C., Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. American Journal of Psychiatry 2006, 163(7):1252-1263.
62. Herbert M.R., Ziegler D.A., Deutsch C.K., O'Brien L.M., Lange N., Bakardjiev A.I., et al. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain 2003, 126(5):1182-1192.
63. Hesse S., Müller U., Lincke T., Barthel H., Villmann T., Angermeyer M.C., Sabri O., Stengler-Wenzke K. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Research 2005, 140(1):63-72.
64. Hoekstra P.J., Steenhuis M.P., Kallenberg C.G., Minderaa R.B. Association of small life events with self reports of tic severity in pediatric and adult tic disorder patients: a prospective longitudinal study. The Journal of Clinical Psychiatry 2004, 65(3):426-431.
65. Hollander E., Anagnostou E., Chaplin W., Esposito K., Haznedar M.M., LiCalzi E.M., et al. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biological Psychiatry 2005, 58(3):226-232.
66. Hollander E., Kim S., Khanna S., Pallanti S. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectroscopy 2007, 12(2 Suppl 3):5-13.
67. Hollander E., King A., Delaney K., Smith C.J., Silverman J.M. Obsessive-compulsive behaviors in parents of multiplex autism families. Psychiatry Research 2003, 117(1):11-16.
68. Huyser C., Veltman D.J., Haan E.d., Boer F. Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder? Evidence from neuroimaging. Neuroscience and Biobehavioral Reviews 2009, 1-13.
69. Hyde T.M., Stacey M.E., Coppola R., Handel S.F., Rickler K.C., Weinberger D.R. Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins. Neurology 1995, 45(6):1176-1182.
70. Insel T.R. Toward a neuroanatomy of obsessive compulsive disorder. Archives of General Psychiatry 1992, 49:739-744.
71. Kahlbaum, K., 1874. Die katatonie oder das spannungsirresein, eine klinische form psychischer krankheit, 1st Hirschwald, Berlin.
72. Kandel, Schwartz and Jessel (1991). Principles of neuroscience (third edition).
73. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943, 2:217-250.
74. Kas M.J., Fernandes C., Schalkwyk L.C., Collier D.A. Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men. Molecular Psychiatry 2007, 12(4):324-330.
75. Kellner C.H., Jolley R.R., Holgate R.C., Austin L., Lydiard R.B., Laraia M., et al. Brain MRI in obsessive-compulsive disorder. Psychiatry Research 1991, 36(1):45-49.
76. Kolevzon, Mathewson, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. The Journal of Clinical Psychiatry 2006, 67(3):407-414.
77. Kraepelin, E., 1899. Psychiatrie: Ein Lehrbuch fur Studirende und Aerzte. Sechste, vollstandig umgearbeitete Auflage., 6th Barth, Leipzig.
78. Lam, Bodfish, Piven J. Evidence for three subtypes of repetitive behavior in autism that differ in familiality and association with other symptoms. Journal of Child Psychology and Psychiatry, and Allied Disciplines 2008, 49(11):1193-1200.
79. Langen M., Durston S., Staal W.G., Palmen S.J., van Engeland H. Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biological Psychiatry 2007.
80. Langen M., Schnack H.G., Nederveen H., Bos, Lahuis B.E., de Jonge M., et al. Changes in the developmental trajectories of striatum in autism. Biological Psychiatry 2009.
81. Langen, M., Kas, M.J.H., Staal, W.G., van Engeland, H. and Durston, S. The neurobiology of repetitive behavior: of mice. Neurosci. Biobehav. Rev. (2010), doi:10.1016/j.neubiorev.2010.02.004.
82. Laplane D., Levasseur M., Pillon B., Dubois B., Baulac M., Mazoyer B., et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain 1989, 112(Pt 3):699-725.
83. Leckman, Goodman W.K., Anderson, Riddle M.A., Chappell P.B., McSwiggan-Hardin M.T., et al. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995, 12(1):73-86.
84. Leckman J.F. Tourette's syndrome. Lancet 2002, 360(9345):1577-1586.
85. Lewis M.H., Tanimura Y., Lee L.W., Bodfish J.W. Animal models of restricted repetitive behavior in autism. Behavioral Brain Research 2007, 176(1):66-74.
86. Luxenberg J.S., Swedo S.E., Flament M.F., Friedland R.P., Rapoport J.L., Rapoport S.I. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative x-ray computed tomography. The American Journal of Psychiatry 1988, 145(9):1089-1093.
87. Makki M.I., Behen M., Bhatt A., Wilson B., Chugani H.T. Microstructural abnormalities of striatum and thalamus in children with Tourette syndrome. Movement Disorders 2008.
88. Maltby N., Tolin D.F., Worhunsky P., O'Keefe T.M., Kiehl K.A. Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study. NeuroImage 2005, 24(2):495-503.
89. Marsh R., Maia T.V., Peterson B. Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies. The American Journal of Psychiatry 2009, 166(6):664-674.
90. McAlonan G.M., Daly E., Kumari V., Critchley H.D., van A.T., Suckling J., et al. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 2002, 125(Pt 7):1594-1606.
91. McGuire, Bench C.J., Frith C.D., Marks I.M., Frackowiak R.S., Dolan R.J. Functional anatomy of obsessive-compulsive phenomena. The British Journal of Psychiatry: The Journal of Mental Science 1994, 164(4):459-468.
92. Mecklinger A.D., von Cramon D.Y., Springer A., Matthes-von Cramon G. Executive control functions in task switching: evidence from brain injured patients. Journal of Clinical and Experimental Neuropsychology 1999, 21(5):606-619.
93. Menzies L., Achard S., Chamberlain S.R., Fineberg N., Chen C.H., del Campo N., Sahakian B.J., Robbins T.W., Bullmore E. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007, 130(12):3223-3236.
94. Menzies L., Chamberlain S.R., Laird A.R., Thelen S.M., Sahakian B.J., Bullmore E.T. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neuroscience and Biobehavioral Reviews 2008, 32(3):525-549.
95. Menzies L., Williams G.B., Chamberlain S.R., Ooi C., Fineberg N., Suckling J., Sahakian B.J., Robbins T.W., Bullmore E.T. White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. The American Journal of Psychiatry 2008, 165(10):1308-1315.
96. Micallef J., Blin O. Neurobiology and clinical pharmacology of obsessive-compulsive disorder. Clinical Neuropharmacology 2001, 24(4):191-207.
97. Mitterschiffthaler M., Ettinger U., Mehta M., Mataix-Cols D., Williams S. Applications of functional magnetic resonance imaging in psychiatry. Journal of Magnetic Resonance Imaging 2006, 23(6):851-861.
98. Müller-Vahl K.R., Meyer G.J., Knapp W.H., Emrich H.M., Gielow P., Brücke T., et al. Serotonin transporter binding in Tourette syndrome. Neuroscience Letters 2005, 385(2):120-125.
99. Ödberg F.O. Future research directions. Stereotypic Animal Behaviour: Fundamentals and Applications to Welfare 1993, CAB International, Wallingford. A.B. Lawrence, J. Rushen (Eds.).
100. Osmon D. Neuropsychological evaluation in the diagnosis and treatment of Tourette's syndrome. Behavior Modification 2005, 29(5):746-783.
101. Peterson B., Riddle M.A., Cohen D.J., Katz L.D., Smith J.C., Hardin M.T., et al. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology 1993, 43(5):941-949.
102. Peterson B.S., Leckman The temporal dynamics of tics in Gilles de la Tourette syndrome. Biological Psychiatry 1998, 44(12):1337-1348.
103. Peterson B.S., Thomas P., Kane M.J., Scahill L., Zhang H., Bronen R., et al. Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Archives Of General Psychiatry 2003, 60(4):415-424.
104. Piaget J. The Origins of Intelligence in the Child 1952, Basic, New York.
105. Plessen K.J., Wentzel-Larsen T., Hugdahl K., Feineigle P., Klein J., Staib L.H., et al. Altered interhemispheric connectivity in individuals with Tourette's disorder. The American Journal of Psychiatry 2004, 161(11):2028-2037.
106. Pogarell O., Hamann C., Pöpperl G., Juckel G., Choukèr M., Zaudig M., et al. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biological Psychiatry 2003, 54(12):1406-1413.
107. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Archives Of General Psychiatry 1994, 51(1):62-70.
108. Reimold M., Smolka M., Zimmer A., Batra A., Knobel A., Solbach C., et al. Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity-a [11c]dasb pet study. Journal of Neural Transmission 2007, 114(12):1603-1609.
109. Remijnse P.L., Nielen M.M., van Balkom A.J., Cath D.C., van Oppen P., Uylings H.B., et al. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Archives of General Psychiatry 2006, 63(11):1225-1236.
110. Robinson D.G., Wu H., Munne R.A., Ashtari M., Alvir J.M., Lerner G., et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Archives of General Psychiatry 1995, 52(5):393-398.
111. Rogers R.D., Sahakian B.J., Hodges J.R., Polkey C.E., Kennard C., Robbins T.W. Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease. Brain 1998, 121(Pt 5):815-842.
112. Rojas D.C., Peterson E., Winterrowd E., Reite M.L., Rogers S., Tregellas J.R. Regional gray matter volumetric changes in autism associated with social and repetitive behavior symptoms. BMC Psychiatry 2006, 6:56.
113. Rosenberg D.R., Keshavan M.S., O'Hearn K.M., Dick E.L., Bagwell W.W., Seymour A.B., et al. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Archives of General Psychiatry 1997, 54(9):824-830.
114. Saresella M., Marventano I., Guerini F.R., Mancuso R., Ceresa L., Zanzottera M., et al. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biological Psychiatry 2009, 66(10):978-984.
115. Sawle G.V., Lees A.J., Hymas N.F., Brooks D.J., Frackowiak R.S. The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome. Journal of Neurology, Neurosurgery & Psychiatry 1993, 56(9):1016-1019.
116. Saxena S., Bota R.G., Brody A.L. Brain-behavior relationships in obsessive-compulsive disorder. Seminars in Clinical Neuropsychiatry 2001, 6(2):82-101.
117. Saxena S., Brody A.L., Maidment K.M., Dunkin J.J., Colgan M., Alborzian S., et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999, 21(6):683-693.
118. Saxena S., Rauch S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Pediatric Clinics of North America 2000, 23(3):563-586.
119. Scarone S., Colombo C., Livian S., Abbruzzese M., Ronchi P., Locatelli M., et al. Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Research: Neuroimaging 1992, 45(2):115-121.
120. Schmahmann J., Pandya D. Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems. Cortex 2008, 30.
121. Schwartz J.M., Stoessel P.W., Baxter L.R., Martin K.M., Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Archives Of General Psychiatry 1996, 53(2):109-113.
122. Sears L.L., Vest C., Mohamed S., Bailey J., Ranson B.J., Piven J. An MRI study of the basal ganglia in autism. Progress in Neuropsychopharmacology & Biological Psychiatry 1999, 23(4):613-624.
123. 123I]FP-CIT/SPECT study. Acta psychiatrica Scandinavica 2004, 109(2):140-146.
124. Shafritz K., Dichter G., Baranek G., Belger A. The neural circuitry mediating shifts in behavioral response and cognitive set in autism. Biological Psychiatry 2008, 63(10):974-980.
125. Simpson H.B., Lombardo I., Slifstein, Huang H.Y., Hwang D.R., Abi-Dargham, et al. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)c]mcn 5652. Biological Psychiatry 2003, 54(12):1414-1421.
126. Singer H., Szymanski S., Giuliano J., Yokoi F., Dogan A.S., Brasic J.R., et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. The American Journal of Psychiatry 2002, 159(8):1329-1336.
127. Singer H.S., Reiss A.L., Brown J.E., Aylward E.H., Shih B., Chee E., et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993, 43(5):950-956.
128. Sohn M.H., Ursu S., Anderson J.R., Stenger V.A., Carter C.S. Inaugural article: the role of prefrontal cortex and posterior parietal cortex in task switching. Proceedings of the National Academic Science of the USA 2000, 97(24):13448-13453.
129. Soomro, G.M., Altman, D., Rajagopal, S., Oakley-Browne, M., 2008. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane database of systematic reviews 23 1: CD001765.
130. Sowell E., Kan E., Yoshii J., Thompson P., Bansal R., Xu D., et al. Thinning of sensorimotor cortices in children with Tourette syndrome. Nature Neuroscience 2008, 11(6):637-639.
131. Srour M., Lespérance P., Richer F., Chouinard S. Psychopharmacology of tic disorders. Journal of the Canadian Academy of Child and Adolescent Psychiatry 2008, 17(3):150-159.
132. Stablum F., Leonardi G., Mazzoldi M., Umiltà C., Morra S. Attention and control deficits following closed head injury. Cortex; A Journal Devoted to the Study of the Nervous System and Behavior 1994, 30(4):603-618.
133. Stein D.J. Neurobiology of the obsessive-compulsive spectrum disorders. Biological Psychiatry 2000, 47(4):296-304.
134. Stein D.J., Coetzer R., Lee M.L., Davids B., Bouwer C. Magnetic resonance brain imaging in women with obsessive-compulsive disorder and trichotillomania. Psychiatry Research 1997, 74(3):177-182.
135. Stein D.J., Hollander E., Chan S., DeCaria C.M., Hilal S., Liebowitz M.R., et al. Computed tomography and neurological soft signs in obsessive-compulsive disorder. Psychiatry Research 1993, 50(3):143-150.
136. Stern E., Silbersweig D.A., Chee K.Y., Holmes A., Robertson M.M., Trimble M., et al. A functional neuroanatomy of tics in Tourette syndrome. Archives of General Psychiatry 2000, 57(8):741-748.
137. Stoetter B., Braun A.R., Randolph C., Gernert J., Carson R.E., Herscovitch P., et al. Functional neuroanatomy of Tourette syndrome. Limbic-motor interactions studied with fdg pet. Advances in Neurology 1992, 58:213-226.
138. Swain J., Scahill L., Lombroso P., King R., Leckman J.F. Tourette syndrome and tic disorders. Journal of the American Academy of Child & Adolescent Psychiatry 2007, 46(8):947-968.
139. Swedo S.E., Pietrini P., Leonard H.L., Schapiro M.B., Rettew D.C., Goldberger E.L., et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Archives of General Psychiatry 1992, 49(9):690-694.
140. Swedo S.E., Schapiro M.B., Grady C.L., Cheslow D.L., Leonard H.L., Kumar A., et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Archives of General Psychiatry 1989, 46(6):518-523.
141. Thakkar K., Polli F., Joseph R., Tuch D., Hadjikhani N., Barton J., et al. Response monitoring, repetitive behaviour and anterior cingulate abnormalities in autism spectrum disorders (asd). Brain 2008, 131(9):2464-2478.
142. Turjanski N., Sawle G.V., Playford E.D., Weeks R., Lammerstma A.A., Lees A.J., et al. Pet studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. Journal of Neurology, Neurosurgery & Psychiatry 1994, 57(6):688-692.
143. Turner K., Frost L., Linsenbardt D., Mcilroy J., Müller R. Atypically diffuse functional connectivity between caudate nuclei and cerebral cortex in autism. Behavioral Brain Functions 2006, 2(1):34.
144. Turner M. Annotation: repetitive behaviour in autism: a review of psychological research. Journal of Child Psychological Psychiatry 1999, 40(6):839-849.
145. Ursu, Stenger V.A., Shear M.K., Jones M.R., Carter C.S. Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychological science: a journal of the. American Psychological Society 2003, 14(4):347-353.
146. van den Heuvel O.A., Remijnse P.L., Mataix-Cols D., Vrenken H., Groenewegen H.J., Uylings H.B., et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 2008.
147. van den Heuvel O.A., Veltman D.J., Groenewegen H.J., Cath D.C., van Balkom A.J., van Hartskamp J., et al. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Archives of General Psychiatry 2005, 62(3):301-309.
148. van der Wee N.J., Ramsey N., Jansma J.M., Denys D.A., van Megen H.J., Westenberg H.M., et al. Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. NeuroImage 2003, 20(4):2271-2280.
149. van der Wee N.J., Stevens H., Hardeman J.A., Mandl R.C., Denys D.A., van Megen H.J., et al. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123i]{beta}-cit spect. American Journal of Psychiatry 2004, 161(12):2201-2206.
150. van Wattum P.J., Chappell P.B., Zelterman D., Scahill L.D., Leckman Patterns of response to acute naloxone infusion in Tourette's syndrome. Movement Disorders 2000, 15(6):1252-1254.
151. Viding E., Blakemore S.J. Endophenotype approach to developmental psychopathology: implications for autism research. Behavior Genetics 2007, 37(1):51-60.
152. Viswanath B., Janardhan Reddy Y.C., Kumar K.J., Kandavel T., Chandrashekar C. Cognitive endophenotypes in OCD: a study of unaffected siblings of probands with familial OCD. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(4):610-615.
153. Voelbel G.T., Bates M.E., Buckman J.F., Pandina G., Hendren R.L. Caudate nucleus volume and cognitive performance: are they related in childhood psychopathology?. Biological Psychiatry 2006, 60(9):942-950.
154. Voon V., Fox S.H. Medication-related impulse control and repetitive behaviors in parkinson disease. Archives of Neurology 2007, 64(8):1089-1096.
155. Voon V., Potenza M.N., Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Current Opinion in Neurology 2007, 20:484-492.
156. Westenberg H.G., Fineberg N.A., Denys D. Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectroscopy 2007, 12(2 Suppl 3):14-27.
157. Whiteside S., Port J., Abramowitz J. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 2004, 132(1):69-79.
158. Wolf S.S., Jones D.W., Knable M.B., Gorey J.G., Lee K.S., Hyde T.M., et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus d2 receptor binding. Science 1996, 273(5279):1225-1227.
159. Zimmerman A.M., Abrams M.T., Giuliano J.D., Denckla M.B., Singer H.S. Subcortical volumes in girls with Tourette syndrome: support for a gender effect. Neurology 2000, 54(12):2224-2229.
160. Zitterl W., Aigner M., Stompe T., Zitterl-Eglseer K., Gutierrez-Lobos K., Schmidl-Mohl B., Wenzel T., Demal U., Zettinig G., Hornik K., Thau K. [123i]-beta-cit spect imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers. Neuropsychopharmacology 2007, 32(8):1661-1668.
161. Zitterl W., Aigner M., Stompe T., Zitterl-Eglseer K., Gutierrez-Lobos K., Wenzel T., et al. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder. Neuropsychopharmacology 2008, 9.
162. Zohar J., Insel T.R. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry 1987, 22(6):667-687.